Morgan Stanley Maintains Overweight on Lazard, Lowers Price Target to $54
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ryan Kenny maintains an Overweight rating on Lazard (NYSE:LAZ) but lowers the price target from $58 to $54.
June 21, 2024 | 2:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley analyst Ryan Kenny maintains an Overweight rating on Lazard but lowers the price target from $58 to $54. This suggests continued confidence in the stock but with a slightly reduced upside potential.
The Overweight rating indicates that Morgan Stanley still sees Lazard as a strong investment, but the lowered price target suggests a tempered outlook on its short-term performance. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100